Considering a putative role in relation to NAFLD/NASH patients, which are mostly obese individuals and/or type II diabetes patients, by inducing HIF-2α stabilization SerpinB3 may represent a factor able to deeply affect lipid metabolism. The gene discussed is SERPINB3; the disease is type 2 diabetes mellitus.